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1. Introduction
Research into the pathogenesis of disease has traditionally
involved a reductionist approach in which discrete inflammatory
pathways and processes are investigated to elucidate underlying
mechanisms. With advances in genomic, epigenetic, proteomic,
and metabolomic capabilities, an increased interest has emerged in
a biologic systems approach to define the complex regulatory
networks that result in health or disease [1] (see Figs. 2e6).
Periodontitis is a complex disease in which disease expression
involves intricate interactions of the biofilm with the host immu-
noinflammatory response and subsequent alterations in bone and
connective tissue homeostasis [2e4].
The basic conceptual model of periodontitis was revised in 1997
(Fig. 1) [5], in great part to acknowledge that various risk factors
operated by modifying host responses led to changes in disease
expression. In this model, host immunoinflammatory mechanisms
are activated by bacterial product. In addition, cytokines and
prostanoids, as well as matrix metalloproteinases activated
through the host response, may stimulate damage to connective
tissue and bone and shape the clinical presentation of disease [6].
Though specific microorganisms are cited as a cause for peri-
odontitis, various other aspects of tissue alterations are also known
to modify the periodontal status adversely. Based on this concept,
presently serum, saliva, tissue biopsy specimens and gingival
crevicular fluid have been investigated for their biochemical con-
stituents [7,8].
Gingival crevicular fluid is generally considered as an initial
transudate/interstitial fluid which later changes to exudates in the
presence of inflammation [9]. It contains a vast array of biochemical
factors, offering potential use as a diagnostic or prognostic
biomarker of the biologic state of the periodontium in health and
disease [10].
Chemokines selectively attract and activate different leukocyte
subpopulations which in turn induce inflammation [11]. RANTES, a
member of the CC chemokine family, displays a significant
chemotactic activity for eosinophils, monocytes and CD þ T cells
[12].
RANTES expression has also been demonstrated in a variety of
other diseases characterized by inflammation, including asthma,
atherosclerosis, endometriosis and fibrosis [13].
Considering the multifunctional ability of monocytes/macro-
phages, these could be directly involved in initiation of develop-
ment of the inflammatory response and alveolar bone loss
observed in periodontitis.
Therefore, analysis of RANTES mechanism that induces mono-
cyte recruitment into periodontal tissues represents an important
step towards understanding the pathogenesis of this disease.
This study envisages to determine the presence of RANTES in
GCF samples in healthy subjects, patients with gingivitis and
periodontitis before and after initial periodontal therapy. The ob-
jectives of the study include assessment and comparisons of the
levels of RANTES in GCF of healthy subjects, patients with gingivitis,
chronic periodontitis and aggressive periodontitis, before and after
2 months following initial periodontal therapy, to correlate the
levels of RANTES in GCF with various periodontal parameters, to
determine whether RANTES can serve as a marker in the identifi-
cation of active phase of periodontal disease.
2. Materials and methods
40 subjects who visited the Department of Periodontics, The
Oxford Dental College, Hospital and Research center, Bangalore
were included in the study. An informed consent was obtained
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from all the subjects. The study period was of 10 months.
Inclusion Criteria: Subjects aged between 18 and 55years, Sys-
temically healthy subjects, No antibiotic/NSAIDs usage in previous
3 month, No history of periodontal treatment in the last 6 months.
2.1. Exclusion criteria
Patients on medications (eg. Corticosteroids, anti inflammatory
drugs, immune modulators), Patients with infectious conditions
other than periodontitis, Medically compromised patients.
2.2. Study design
A total of 40 subjects were recruited and were divided into 4
groups.
Group 1 included 10 patients diagnosed with chronic peri-
odontitis with probing pocket depth > 5mm and clinical attach-
ment loss > 3mm with radiographic evidence of bone loss. In this
group 5 patients having localized periodontitis and 5 with gener-
alized periodontitis were included.(Photograph1).
Group 2 included ten patients with aggressive periodontitis. In
this group 5 patients having localized aggressive periodontitis and
5 with generalized aggressive periodontitis were
included.(Photograph2).
Group 3 included 10 patients with gingivitis. In this group 5
patients having localized gingivitis and 5 with generalized gingi-
vitis were included.(Photograph 3).
Group 4 consisted of 10 systemically and clinically healthy
Fig. 1. The evolution of conceptual models of periodontal disease. A) An early linear model depicting the principal etiologic role for bacteria in the initiation and progression of
periodontal disease. B) Circa 1980s model emphasizing a central role for the host immunoinflammatory response in the clinical development and progression of periodontal
disease. C) A 1997 model demonstrating various factors contributing to the pathogenesis of human periodontitis based on pathways and processes known at the time.
Fig. 2. Chronic periodontitis. Before NON surgical periodontal therapy. Fig. 3. AGGRESSIVE periodontitis. Before NON surgical periodontal therapy.
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subjects with no signs of any form of periodontal disease.(Photo-
graph 4).
At first visit the following clinical parameters were recorded for
all the subjects:
Plaque index, Gingival Index, Probing pocket depth in mm,
Clinical attachment loss (CAL) in mm. Pooled sample of GCF was
collected after isolationwith a cotton roll, supragingival plaquewas
removed avoiding contact with themarginal gingiva. The crevicular
sites were gently dried with an air syringe. Gingival crevicular fluid
was obtained before probing the site by placing colour coded
1e5 mL calibrated volumetric micro-capillary pipettes and a mini-
mumvolume of 3 mL pooled sample was obtained by placing the tip
of the pipette extracrevicularly at the gingival margin (Photograph
5). Samples of gingival crevicular fluid contaminated by blood or
saliva were discarded. The sample was immediately transferred to
an eppendorf tube containing 9 ml of phosphate buffer saline.
This tube was kept in a thermocol transport case with ice packs
to maintain temperature at 0 C till it was transferred to the
refrigerator. Within 12 h samples were transferred to 80 C
refrigerator at St. Johns Medical College till the time of assay.
The patients in the first three groups were then given nonsur-
gical periodontal therapy (scaling and root planning) in two ap-
pointments within a weeks time and then followed for up to 8
weeks. In their visit after 8 weeks all the above data (plaque index,
gingival index, probing sulcus depth, clinical attachment level and
GCF sample) were collected in the same fashion as in their first visit.
GCF samples were assayed by an enzyme linked immunosor-
bent assay (ELISA, Autoplex Elisa Workstation) to determine
RANTES using matched antibody pairs following manufacturer's
recommendation.
This assay employs the quantitative sandwich enzyme immu-
noassay technique. A monoclonal antibody specific for RANTES has
been pre-coated onto a microplate. Standards and samples are
pipetted into the wells and any RANTES present is bound by the
immobilized antibody. After washing away any unbound sub-
stances, an enzyme-linked polyclonal antibody specific for RANTES
is added to the wells. Following a wash to remove any unbound
antibody-enzyme reagent, a substrate solution is added to thewells
and color develops in proportion to the amount of RANTES bound
in the initial step. The color development is stopped and the in-
tensity of the color is measured.
2.3. Statistical Analysis [14,15,16,17]
Data was tabulated and graphs were made for comparing the
mean of three or more groups, ANOVA/Kruskal-Wallis test was
used, followed by Bonferroni/Mann-Whitney test for pair-wise
comparisons. For comparing the change in a parameter within a
group at different time intervals paired t-test/Wilcoxon Signed
Ranks test was used.
Karl Pearson's/Spearman's Rank Correlation was applied to test
the relationship between two variables.
3. Results
Out of the total of 40 subjects, comprising of 23 males and 17
females who participated in this study, the correlation between
baseline and 8 weeks post treatment parameters in the first three
groups who had undergone nonsurgical periodontal therapy was as
follows:
The reduction in PI, GI, PPD, CAL from baseline to post treatment
was found to be statistically significant in the first three groups
(P< .001)
The reduction in RANTES from baseline to post treatment was
also found to be statistically significant in these three groups
(P< .001) (Table 1). The mean RANTES in chronic periodontitis
group at baseline was 61.03± 18.87 and post treatment was
37.97± 12.29, while in aggressive periodontitis group it was
82.19± 14.63 at baseline and 54.24± 10.62 post treatment. In the
gingivitis group it was 39.76± 6.88 at baseline and 12.34± 4.76
post treatment.
Fig. 4. Gingivitis. Before NON surgical periodontal therapy.
Fig. 5. Healthy subject.
Fig. 6. Collection of GCF in micropipette.
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3.1. Comparison of RANTES between the four groups at baseline and
post treatment
Higher mean RANTES was recorded in aggressive periodontitis
group followed by chronic periodontitis group, gingivitis group and
healthy group respectively. The difference in mean RANTES be-
tween these groups was found to be statistically significant
(P< .001).(Table 2 and 3).
3.2. Correlation between RANTES and other parameters in chronic
periodontitis group
The correlation between RANTES and PI, GI, PPD, CAL at baseline
and post treatment was found to be positive but very weak and not
statistically significant (P> .05).(Table 4).
3.3. Correlation between RANTES and other parameters in
aggressive periodontitis group
The correlation between PI and RANTES post operatively was
found to be strong and statistically significant (P< .05) in compar-
ison to relation between RANTES and PI at baseline. However, there
was no correlation between GI, PPD, CAL& RANTES postoperatively
and at baseline (P> .05). (Table 5).
3.4. Correlation between RANTES and other parameters in gingivitis
group
There was no statistically significant correlation between
RANTES and PI,GI,PPD, CAL at baseline and post treatment (P> .05).
(Table 6 and 7).
3.5. Correlation between RANTES and other parameters in healthy
group
The correlation between RANTES and PI was found to be strong
statistically significant (P< .05). Whereas the correlation between
GI, PPD, CAL and RANTES was not statistically significant (P> .05).
4. Discussion
The assessment of periodontal disease and the effectiveness of
periodontal therapy have been traditionally made using clinical and
radiographic parameters. Neverless, recent advances in the un-
derstanding of natural history of periodontal disease have raised
questions about the significance of these diagnostic criteria [18,19].
In our study we used the micropipette methodology as we
needed to collect 3 ml of GCF for qualitative analysis. All the samples
were collected at 11 a.m. in the morning as GCF is considered to
show circadian periodicity. (Bissada et al., 1967) [20].
RANTES is a member of the CC chemokines, with significant
chemotactic activity for eosinophils, monocytes and CD45 þ T cells.
The previous data suggest a role for RANTES in acute and chronic
inflammation. The potential value of RANTES as a marker has been
identified bymany authors like Gamonal J, Acevedo A and Bascones
A [12]. Based on their findings, the present study was designed to
analyze the levels of RANTES in chronic periodontitis, aggressive
periodontitis, gingivitis and healthy subjects. In disease RANTES
level was compared before and after periodontal therapy. The ef-
ficacy of periodontal therapy in controlling the disease activity was
assessed by comparing the levels of RANTES with clinical param-
eters like plaque index, gingival index, probing pocket depth and
clinical attachment level.
In the present study, a total of 40 subjects were recruited and
were divided into 4 groups:
The percentage of males and females were 90% and 10% in group
Table 1
Comparison of RANTES: (Paired t-test).
Group Time interval Mean Std dev SE of Mean Mean difference t P-Value
Chronic Periodontitis Baseline 61.03 18.87 5.97 23.060 5.748 <.001a
Post Treatment 37.97 12.29 3.89
Aggressive Periodontitis Baseline 82.19 14.63 4.63 27.950 8.154 <.001a
Post Treatment 54.24 10.62 3.36
Gingivitis Baseline 39.76 6.88 2.18 27.422 12.099 <.001a
Post Treatment 12.34 4.76 1.51
a Denotes significant difference/change.
Table 2
Comparison of RANTES between the four groups at baseline: (ANOVA followed by Bonferroni test).
Group Mean Std dev SE of Mean Min Max F P-Value Sig diff between
1. Chronic Periodontitis 61.03 18.87 5.97 31.90 91.90 41.434 <.001a 1vs2, 1vs3, 1vs4
2. Aggressive Periodontitis 82.19 14.63 4.63 52.50 101.50 2vs3, 2vs4
3. Gingivitis 39.76 6.88 2.18 29.80 51.20 3vs4
4. Healthy 21.63 6.78 2.14 10.50 31.10
a Denotes significant difference.
Table 3
Comparison of RANTES between the three groups post treatment: (ANOVA followed by Bonferroni test).
Group Mean Std dev SE of Mean Min Max F P-Value Sig diff between
1. Chronic Periodontitis 37.97 12.29 3.89 21.10 61.90 46.718 <.001a 1vs2, 1vs3
2. Aggressive Periodontitis 54.24 10.62 3.36 39.80 81.40 2vs3
3. Gingivitis 12.34 4.76 1.51 1.98 18.10
a Denotes significant difference.
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1 respectively, this is in agreement with previous studies which
state that males show more prevalence of chronic periodontitis
than females [21]. The percentage of males and females 20% and
80% in group 2 respectively, which is in accordance with earlier
reports by Burmister and Best [22]. The percentage of males and
females 90% and 10% in group 3 and 30% and 70% in group 4
respectively which may be due to female patients showing pref-
erence to visit dental hospitals and also women get motivated
easily to participate in research programs than males. Higher
RANTES was observed in female patients than male patients with
matched age and disease severity both at baseline and at post
therapy.
As healthy subject group did not have any treatment and follow
up, the other three groups were compared before and 2 months
after non surgical periodontal therapy; decrease in plaque index
after periodontal therapy in all the three groups was statistically
significant and maximum mean difference was seen in chronic
periodontis (1.569) followed by aggressive periodontitis group
(1.295) and gingivitis group (0.895). This can be attributed to the
presence of statistically significant difference in plaque scores at
baseline within the selected groups and maximum initial plaque
score in chronic periodontitis group.
The reduction in GI from baseline to post treatment was found
to be statistically significant in all the three groups. Maximum
mean difference was seen in chronic periodontis (1.340) followed
by aggressive periodontitis group (1.202) and gingivitis group
(0.462). This can be explained by the fact that chronic periodontitis
is an plaque induced condition associated with gingival inflam-
mation and once plaque load was reduced by effective periodontal
therapy, gingival inflammation and gingival index was reduced.
However in aggressive periodontitis, plaque score does not
commensurate with gingival changes and disease activity [7].
The reduction in PPD from baseline to post treatment was found
to be statistically significant in all the three groups. Maximum
mean difference was seen in aggressive periodontitis group (1.390)
followed by chronic periodontitis (1.150) and PPD in gingivitis
group was (0.353). This can be attributed to the presence of sta-
tistically significant difference in probing pocket depth at baseline
within the selected groups and maximum initial probing pocket
depth in aggressive periodontitis group.
The reduction in CAL from baseline to post treatment was found
to be statistically significant in both the groups. Maximum mean
difference was seen in aggressive periodontitis group (1.290) fol-
lowed by chronic periodontitis (1.820) which is in accordance with
consensus reached by other authors like Lindhe and Socransky for
outcome of non surgical periodontal therapy [23].
The reduction in RANTES from baseline to post treatment was
found to be statistically significant in all the three groups., with
maximum decrease in aggressive periodontitis group followed by
gingivitis group and chronic periodontitis group.
Higher mean RANTES was recorded in aggressive periodontitis
group followed by chronic periodontitis group, gingivitis group and
healthy group respectively at baseline and post treatment.
The most common inflammatory cytokines are IL-1a,IL-1b,IL-
6,IL-8 and TNF-a are primarily responsible for disease initiation
[24]. If the host response to oral infection is only temporary, the
inflammation serves as immune protection and begins the wound
healing [25]. However after prolonged exposure to periodontal
pathogens, the cytokines released by PMNs, such as IL-1a,IL-1b,IL-
6,IL-8 and TNF-a are responsible for initiating the secondary
proinflammatory response, which consists of chemokines as well.
During this phase of inflammation considerable tissue damage can
potentially occur, leading the host into chronic inflammation and
further destruction [26]. Therefore increased chemokines are
anticipated in chronic infection but in the present study higher
levels of RANTES was found in aggressive periodontitis group
which may be attributed to, all the patients being in active phase of
disease as suggested by clinical parameters and also aggressive
periodontitis is a rapidly progressive disease. As said by Garrison
and Nicholas in 1989, hyperinflammatory monocyte phenotype
with increased expression of MCP-1 represents a risk factor for
aggressive periodontitis. So MCP-1 may function either directly or
synergistically with other inflammatory mediators, thereby
involving in the amplification and continuation of the inflammator
[27].
RANTES have now been implicated in the complex interaction of
the several aspects of T-lymphocyte biology that could contribute
to the symptoms of periodontal disease (Ward & Westwick 1998).
RANTES is an efficient chemoattractant of Th1 cells that predomi-
nantly control cell-mediated immune responses. Thereby, it was
stated that they could mediate the complex network of interactions
within the immune system by controlling the balance between
proinflammatory and anti-inflammatory T cell subsets (Gamonal
et al., 2001) Recent studies have shown the presence of high levels
of GCF RANTES in patients with chronic periodontitis and these
levels have been shown to be related to the active attachment loss
and advanced periodontal destruction (Gamonal et al., 2000a, b,
Table 4
Correlation between RANTES and other parameters in Chronic Periodontitis group.
Parameter Baseline Post Treatment
r/r P-Value r/r P-Value
PIa 0.097 .790 0.091 .802
GIa 0.215 .550 0.202 .575
PPDb 0.579 .079 0.220 .779
CALb 0.116 .751 0.037 .920
a Karl Pearson's correlation (r).
b Spearman's Rank correlation (r).
Table 5
Correlation between RANTES and other parameters in Aggressive Periodontitis
group.
Parameter Baseline Post Treatment
r/r P-Value r/r P-Value
PIϮ 0.550 .100 0.640 .046*
GIϮ 0.519 .125 0.096 .791
PPDf 0.394 .260 0.292 .413
CALf 0.256 .475 0.367 .297
Table 6
Correlation between RANTES and other parameters in Gingivitis group.
Parameter Baseline Post Treatment
r/r P-Value r/r P-Value
PIa 0.588 .074 0.453 .189
GIa 0.434 .210 0.028 .939
PPDf 0.457 .184 0.298 .403
CALf 0.457 .184 0.298 .403
a Karl Pearson's correlation (r).
Table 7
RANTES level in GCF.
Baseline Post Treatment
Chronic Periodontitis 61.03 37.97 18.87 12.29
Aggressive Periodontitis 82.19 54.24 14.63 10.62
Gingivitis 39.76 12.34 6.88 4.76
Healthy 21.63 6.78
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2001). In the present study, elevated RANTES levels were present in
aggressive periodontitis. It is possible that MCP-1 releasing from
activated monocyte at sites of inflammation could indirectly
amplify monocyte functions by recruiting additional cells to the
inflammatory site and could contribute to severe periodontal
destruction in aggressive periodontitis patients [27].
The presence of RANTES in healthy individuals could be related
with the steady state of the gingiva, considering this is a site of
permanent antigenic insult, requiring the presence of neutrophils,
macrophages and antigen presenting cells [12]. The presence of
RANTES in GCF could be involved in the development of the
gingival inflammatory response by mediating leukocyte recruit-
ment and activation. This is in agreement with authors like
Gamonal J, Bascones A, Jorge O, Silva A, who detected RANTES in
sulcus less than 3mm [28].
The marked reduction of RANTES in GCF following treatment
observed in the present study clearly suggests a relationship be-
tween disease and chemokine production. The higher decrease in
RANTES level in gingivitis group compared to chronic periodontitis
group may be because gingivitis is a reversible condition which
responds well to periodontal therapy alone where as chronic
periodontitis does not always respond to periodontal therapy
alone, it further needs surgical intervention for effective results. But
the question remains unanswered in our study is the exact cut off
value/range for RANTES level in GCF that could help us decide if a
particular site needs surgical therapy or only non surgical therapy
which includes periodontal therapy followed by maintenance that
would be sufficient.
In our study none of the patients belonging to aggressive peri-
odontitis group were prescribed antibiotics post periodontal ther-
apy to prevent any alteration in microbial compositionwhich could
affect RANTES levels in GCF. Thus the minimum changes in levels of
GCF RANTES noted in aggressive periodontitis group as compared
to gingivitis group could thus be attributed to lack of antimicrobial
therapy in aggressive periodontitis cases.
As shown by our results, higher RANTES levels were detected in
GCF from periodontitis patients than from healthy subjects.
Moreover, RANTES levels in GCF could not be correlated with any of
the clinical parameters tested in the present study. This is in
agreement with other studies measuring cytokines in GCF[29,30]
and may be explained by the fact that clinical parameters such as
plaque index, gingival index, pocket depth and attachment loss do
not necessarily represent current disease activity.
Our results suggest that chemokine production could be critical
to control the type of T cell immune response in a given tissue. An
attempt to correlate the absence or presence of Th1 or Th2 cells
with the progression of the disease could deserve further study.
Several authors have previously described the presence of IL-8
and MCP-1 chemokines in GCF (Chung et al., 1997, Mathur et al.,
1996, Murphy 1996, Tonetti et al., 1994). We have determined that
higher levels of RANTES are found in GCF from patients with
periodontitis as compared to healthy subjects. Considering that
gingival inflammation develops in parallel to increasing infiltration
of monocytes/macrophages and lymphoid cells, it suggests that in
periodontitis, the migration and accumulation of these cells in in-
flammatory loci might be related to the release of chemokines, such
as RANTES, providing a potential mechanism to account for the
recruitment of inflammatory cells observed in bacterially induced
inflammatory processes in human gingiva.
According to the results obtained from the present study, it can
be concluded that GCF levels of RANTESwere significantly higher in
periodontal disease than in healthy subjects. This could be attrib-
uted to inflammatory response and host defense mechanism that
are instigated in disease.
The RANTES level decreased significantly after periodontal
therapy in all the three groups. Although there was a statistical
difference between values in all the three groups, the range was
limited. Therefore further research and longitudinal studies with
increased sample size are needed before levels of RANTES in GCF
can be used accurately as a diagnostic/prognostic marker of disease
activity.
Moreover since we could not reach to an exact standard value of
GCF RANTES which could be accurate to differentiate between
health and disease and active and inactive sites post periodontal
therapy, we suggest that reduction in GCF RANTES after therapy is
useful only in reflecting short term healing and decisions regarding
the need for further treatment and surgical intervention cannot be
taken based on the reduced value of GCF RANTES alone.
5. Conclusions
According to the results obtained from the present study, it can
be concurred that GCF levels of RANTES were significantly higher in
periodontal disease than in healthy subjects. This could be attrib-
uted to inflammatory response and host defense mechanism that
are instigated in disease.
The RANTES level decreased significantly after periodontal
therapy in all the three groups. Although there was a statistical
difference between values in all the three groups, the range was
limited. Therefore further research and longitudinal studies with
increased sample size are needed before levels of RANTES in GCF
can be used accurately as a diagnostic/prognostic marker of disease
activity.
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